Incidence of 22q11.2 Deletion Syndrome
22q11.2 deletion syndrome occurs in approximately 1 in 2,000 to 1 in 4,000 live births, making it the most common microdeletion syndrome in humans. 1, 2, 3
Population Prevalence
- The American College of Medical Genetics and Genomics reports the incidence as 1 in 2,000 to 1 in 3,000 live births based on genetic studies 1
- Alternative estimates place the frequency at 1 in 4,000 live births 2
- This represents the most common microdeletion syndrome affecting humans 1
Inheritance Patterns and Recurrence Risk
The majority (85-95%) of cases occur as de novo deletions, meaning they arise spontaneously rather than being inherited from a parent 4, 1
- Only 5-10% of cases are inherited from an affected parent 4, 1
- Among inherited cases, up to 25% of deletions are familial 1
- One large cohort study found 17.2% parental transmission rate, with preferential maternal transmission (10 of 15 cases) 5
- In the Children's Hospital of Philadelphia cohort of 1,421 patients, only 7% of typical deletions were inherited from a parent 3
Recurrence Risk for Affected Individuals
Affected individuals have a 50% chance of transmitting the deletion to each offspring, regardless of whether they are male or female 4, 1, 6
- This 50% recurrence risk applies to all affected individuals due to the autosomal dominant inheritance pattern 4
- Offspring of affected individuals also have an increased risk of congenital heart defects beyond the baseline 50% deletion transmission risk 6
- When neither parent has the deletion (de novo case), there is a small elevated recurrence risk in future pregnancies due to rare germline mosaicism 4
Clinical Implications for Detection
Many adults with 22q11.2 deletion remain undiagnosed, particularly those without typical congenital anomalies or who were born before confirmatory testing became available 4
- The variable phenotype presents significant diagnostic challenges 4
- Many adults are diagnosed only after the birth of an affected child 4
- Some sudden and/or premature deaths in the general population may represent undiagnosed 22q11.2 deletion syndrome 7
- Parental testing should be performed regardless of parental phenotype, as extremely mild clinical features can occur in affected parents 5